Benjamin P. Linas MD
Professor, Infectious Diseases
Professor, Epidemiology
771 Albany St | (617) 414-5238belinas@bu.edu
benjamin.linas@bmc.org
Sections
Infectious Diseases
Biography
Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.
Websites
Boston-Providence Center for AIDS Research
NIDA Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV
Education
Medicine, MD, New York University School of Medicine
Clinical Evaluation/Research, MPH, Harvard School of Public Health
Economics, BA, Yale University
Publications
Munroe S, Schackman BR, Madkins K, Saber R, Macapagal K, Vititow J, Sweeney N, Feder NM, Benbow N, Mustanski B, Linas BP. Economic Evaluation of Delivering an Evidence-Based Online HIV Prevention Program to MSM via Direct-To-Consumer Marketing Versus Community-Based Organization Recruitment. J Acquir Immune Defic Syndr. 2025 Mar 01; 98(3):257-264. PMID: 39621530.
Published on 2/28/2025Torres TS, Saha PT, Smeaton L, Wimbish C, Kliemann DA, Avihingsanon A, Kityo C, Bennet JA, Van Schalkwyk M, Linas B, Nunes EP, Robbins GK, Wyles D, Naggie S, Sulkowski M, Cardoso SW, Solomon S. Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life. Qual Life Res. 2025 Feb 28. PMID: 40019678.
Published on 2/24/2025Singh RP, Biondi B, Gordon SH, Linas BP, Epstein RL. Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines. JAMA. 2025 Feb 24. PMID: 39992633.
Published on 2/24/2025Epstein RL, Munroe S, Taylor LE, Duryea PR, Buzzee B, Pramanick T, Feld JJ, Baptiste D, Carroll M, Castera L, Sterling RK, Thomas A, Chan PA, Linas BP. Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study. Clin Infect Dis. 2025 Feb 24; 80(2):300-313. PMID: 39535186.
Published on 2/19/2025Chalouni M, Van Santen DK, Berenguer J, Jarrin I, Miro JM, Klein MB, Young J, Torgersen J, Rentsch CT, Gill MJ, Epstein RL, Linas B, Zangerle R, Surial B, Rauch A, Touloumi G, Papadopoulos A, Wittkop L, Van Der Valk M, Boyd A, Monforte AD, Puoti M, Logan RW, Rein SM, Hernán MA, Lodi S. Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus. AIDS. 2025 Feb 19. PMID: 39970192.
Published on 1/22/2025Kaufmann ND, Mazor KM, Marathe J, Linas BP, Fisher KA. Primary Care Physicians' Preparedness to Recognize and Evaluate Patients for Long COVID. J Gen Intern Med. 2025 Jan 22. PMID: 39843672.
Published on 10/1/2024Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP. Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts. JAMA Netw Open. 2024 Oct 01; 7(10):e2437233. PMID: 39412807.
Published on 9/17/2024Castry M, Tin Y, Feder NM, Lewis N, Chatterjee A, Rudorf M, Samet JH, Beers D, Medley B, Gilbert L, Linas BP, Barocas JA. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder. J Subst Use Addict Treat. 2024 Dec; 167:209517. PMID: 39299504.
Published on 9/12/2024Sprague Martinez L, Sharma N, John J, Battaglia TA, Linas BP, Clark CR, Hudson LB, Lobb R, Betz G, Ojala O'Neill SO, Lima A, Doty R, Rahman S, Bassett IV. Publisher Correction: Long COVID impacts: the voices and views of diverse Black and Latinx residents in Massachusetts. BMC Public Health. 2024 Sep 12; 24(1):2483. PMID: 39267034.
Published on 8/21/2024Sprague Martinez L, Sharma N, John J, Battaglia TA, Linas BP, Clark CR, Hudson LB, Lobb R, Betz G, Ojala O'Neill SO, Lima A, Doty R, Rahman S, Bassett IV. Long COVID impacts: the voices and views of diverse Black and Latinx residents in Massachusetts. BMC Public Health. 2024 Aug 21; 24(1):2265. PMID: 39169314.
Media Mentions
Published on 7/26/2024
How to combat a new surge of COVID-19 cases
Published on 11/6/2023
How to protect yourself from the 'tripledemic' of COVID-19, flu and RSV this winter
Published on 5/11/2023
Ask The Docs: the COVID emergency ends, and a new RSV vaccine in the works
Published on 2/14/2023
Boston Doctors Explain What to Know as Norovirus Cases Spread in Mass.
Published on 2/14/2023
The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word
Published on 2/7/2023
US to Stop Offering Free COVID Vaccines This Fall: What it Means For Mass.
Published on 1/24/2023
Boston doctors answer listener questions about COVID
Published on 1/8/2023
Health Check: Diversity in Clinical Trials
Published on 11/22/2022
New COVID Variant Becomes Predominant Strain in New England
Published on 11/1/2022
As New COVID Variants Continue to Spread, Boston Doctors Wonder, ‘What's the Plan?'
View full list of 162 media mentions.